4th mRNA Based Therapeutics Summit

where we are

We are excited to announce that several of our esteemed experts will be attending the 4th mRNA Based Therapeutics Summit, a pivotal international conference in the mRNA field. Among the highlights, our R&D Manager, Kelly, will deliver an insightful presentation titled "Overcoming dsRNA Challenge: Innovation in Assays & Enzymes."

Presenters Biography

A R&D Manager of Vazyme Biotech, In 2021, She joined Vazyme Biotech as the project manager of the analytical department, mainly developing quality analysis methods for mRNA vaccines, which already has a complete set of solutions for mRNA quality analysis, and the related products and technologies are at the leading level in China, and the project products have a wide range of application prospects in the field of mRNA vaccines. At the same time, she participated in the development of mRNA vaccine raw materials and mRNA vaccine quality control products, and further expanded the company’s related product lines.

She was a postdoctoral fellow at Nanjing University, participated in a number of major national projects such as key projects of the National Natural Science Foundation of China during his master’s and doctoral studies, received daily postdoctoral funding from Jiangsu Province during his postdoctoral period, and achieved a number of research achievements in the field of bioinorganics, participated in the publication of 8 SCI papers, and applied for 7 national invention patents.

Key Learning Objective

Optimization of IVT-PP for dsRNA is challenging
Next-Generation T7: Overall performance enhanced
ds-SensorTM: State-of-the-art dsRNA assay

Join us together

This summit will gather over 350 mRNA experts and enthusiasts, featuring 65+ world-class speakers from renowned companies such as CureVac, Moderna, BioNTech, and Sanofi. Attendees will also gain exclusive regulatory insights from the FDA, MHRA, and EMA.

We invite everyone to visit us at Booth 38 for in-depth discussions and to learn more about our innovative solutions.

Our participation underscores our commitment to advancing mRNA technology and solidifies our presence on the global stage!

Welcome to the Premier 4th mRNA-Based Therapeutics Summit!

Expect to see 65+ world-class speakers bringing you unseen data spanning proof-of-concept studies, platform development, clinical updates and regulatory insights, with a reinvigorated focus on rare and oncological diseases, personalized medicine, gene editing and cell therapy mRNA applications as the field progresses towards bringing novel drugs to patients faster.

Across 4 jam-packed streams of content, we are bringing together 350+ global attendees to tap into unmissable scientific breakthroughs and valuable insights to propel your mRNA pipelines forward:

Discovery – Kickstart your mRNA journey by diving into advanced drug discovery platforms, next generation gene editing tools, AI-led drug design, and increasing your functional expression
Translation – Maximize translatability into the clinic by accessing expert case studies to unlock your circular and self-replicating RNA technologies, in vivo cell engineering, and assay development strategies
Clinical Development – Explore the latest mRNA therapeutic and vaccine trial data, tackling rare, infectious and oncological diseases through gene editing, personalized therapies and self-replicating RNA
Chemistry, Manufacturing & Controls – Ensure cost-effective manufacturing with novel platform strategies, analytical tools and formulation approaches to accelerate mRNA drug production at all scales